EGFR and cancer: High EGFR levels are linked to an elevated risk of invasion and metastasis [26], while EGFR inhibition reduces cancer cell proliferation, migration and angiogenesis, and enhances apoptosis in solid tumors [27].The findings of Weng et al. [26] that hypermethylation of the EFGR promoter is associated with its increased expression is unusual.